Ocular Therapeutix logo

Ocular Therapeutix OCUL

$ 6.87 2.5%
report update icon

Quarterly report 2026-Q2
added 08-03-2026

Country

usaUSA

IPO year

2014

Industry

Biotechnology

Stock Exchange

NASDAQ GLOBAL

Shares

187 M

Market Cap[1]

$ 1.29 B

EBITDA (LTM)

$ -266 M

P/E (LTM)

-7.492958

P/S (LTM)

38.348624

EPS (LTM)

-1.42

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Keros Therapeutics Keros Therapeutics
KROS
$ 10.66 0.45 % $ 397 M Nasdaq Global Select Market usaUSA
XBiotech XBiotech
XBIT
$ 2.12 1.67 % $ 64.6 M Nasdaq Global Select Market usaUSA
Xenon Pharmaceuticals Xenon Pharmaceuticals
XENE
$ 33.49 1.27 % $ 2.65 B Nasdaq Global Select Market canadaCanada
Xeris Pharmaceuticals Xeris Pharmaceuticals
XERS
$ 10.31 2.38 % $ 1.65 B Nasdaq Global Select Market usaUSA
X4 Pharmaceuticals X4 Pharmaceuticals
XFOR
$ 2.59 0.19 % $ 110 M Nasdaq Capital Market usaUSA
Kodiak Sciences Kodiak Sciences
KOD
$ 85.75 0.64 % $ 4.56 B Nasdaq Global Market,SPB usaUSA
22nd Century Group 22nd Century Group
XXII
$ 0.34 0.98 % $ 62.6 K NYSE American usaUSA
Halozyme Therapeutics Halozyme Therapeutics
HALO
$ 121.84 0.27 % $ 14.6 B Nasdaq Global Select Market,SPB usaUSA
Arvinas Arvinas
ARVN
$ 6.97 1.12 % $ 494 M Nasdaq Global Select Market,SPB usaUSA
Zai Lab Limited Zai Lab Limited
ZLAB
$ 23.19 0.79 % $ 25.4 B Nasdaq Global Select Market chinaChina
Zentalis Pharmaceuticals Zentalis Pharmaceuticals
ZNTL
$ 2.13 0.83 % $ 153 M Nasdaq Global Market usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
$ 1.6 1.78 % $ 426 M Nasdaq Global Select Market britainBritain
BridgeBio Pharma BridgeBio Pharma
BBIO
$ 66.39 3.37 % $ 12.7 B Nasdaq Global Select Market,SPB usaUSA
PMV Pharmaceuticals PMV Pharmaceuticals
PMVP
$ 1.21 4.03 % $ 63.6 M Nasdaq Global Select Market usaUSA
Harmony Biosciences Holdings Harmony Biosciences Holdings
HRMY
$ 37.95 0.17 % $ 2.18 B Nasdaq Global Select Market usaUSA
Kazia Therapeutics Limited Kazia Therapeutics Limited
KZIA
$ 7.25 0.54 % $ 111 M Nasdaq Global Select Market australiaAustralia
CNS Pharmaceuticals CNS Pharmaceuticals
CNSP
$ 4.85 3.08 % $ 2.15 M Nasdaq Capital Market usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
MacroGenics MacroGenics
MGNX
$ 3.25 1.81 % $ 205 M Nasdaq Global Select Market usaUSA
iBio iBio
IBIO
$ 0.77 0.63 % $ 80.1 M NYSE American usaUSA
Cytokinetics, Incorporated Cytokinetics, Incorporated
CYTK
$ 61.95 0.77 % $ 7.44 M Nasdaq Global Select Market,SPB usaUSA
Immunome Immunome
IMNM
$ 16.47 1.16 % $ 1.44 B Nasdaq Global Select Market usaUSA
Immuron Limited Immuron Limited
IMRN
$ 0.98 0.49 % $ 226 M Nasdaq Global Select Market australiaAustralia
Moderna Moderna
MRNA
$ 218.01 4.51 % $ 84.8 B Nasdaq Global Select Market,SPB usaUSA
InMed Pharmaceuticals InMed Pharmaceuticals
INM
$ 1.32 0.38 % $ 5.5 M Nasdaq Capital Market canadaCanada
INmune Bio INmune Bio
INMB
$ 1.57 3.12 % $ 38.9 M Nasdaq Capital Market usaUSA
Inovio Pharmaceuticals Inovio Pharmaceuticals
INO
$ 0.99 5.48 % $ 46.4 M Nasdaq Global Select Market usaUSA
Insmed Incorporated Insmed Incorporated
INSM
$ 96.27 1.45 % $ 19.2 B Nasdaq Global Select Market usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$ 10.78 4.62 % $ 697 M NYSE usaUSA
Biogen Biogen
BIIB
$ 232.65 0.1 % $ 34.1 B Nasdaq Global Select Market,SPB usaUSA
BioVie BioVie
BIVI
$ 1.2 6.19 % $ 1.77 M Nasdaq Capital Market usaUSA
Ionis Pharmaceuticals Ionis Pharmaceuticals
IONS
$ 42.94 3.33 % $ 6.87 B Nasdaq Global Select Market,SPB usaUSA
Innate Pharma S.A. Innate Pharma S.A.
IPHA
$ 1.43 0.54 % $ 128 M Nasdaq Global Select Market franceFrance
NextCure NextCure
NXTC
$ 6.24 4.56 % $ 17.7 M Nasdaq Global Select Market usaUSA
BeyondSpring BeyondSpring
BYSI
$ 0.56 3.09 % $ 23 M Nasdaq Capital Market usaUSA
Capricor Therapeutics Capricor Therapeutics
CAPR
$ 6.71 10.32 % $ 312 M Nasdaq Capital Market usaUSA
Oncolytics Biotech Oncolytics Biotech
ONCY
$ 0.5 1.75 % $ 47.9 M Nasdaq Global Select Market canadaCanada
Outlook Therapeutics Outlook Therapeutics
OTLK
$ 0.49 0.04 % $ 17.1 M Nasdaq Global Select Market usaUSA
Protagonist Therapeutics Protagonist Therapeutics
PTGX
$ 128.75 0.2 % $ 8.19 B Nasdaq Global Select Market usaUSA
Passage Bio Passage Bio
PASG
$ 3.5 4.44 % $ 11.2 M Nasdaq Global Select Market usaUSA
Forte Biosciences Forte Biosciences
FBRX
$ 76.99 0.03 % $ 997 M Nasdaq Capital Market usaUSA
Mirum Pharmaceuticals Mirum Pharmaceuticals
MIRM
$ 80.14 3.04 % $ 4.02 B Nasdaq Global Select Market usaUSA
Inhibikase Therapeutics Inhibikase Therapeutics
IKT
$ 1.65 1.67 % $ 162 M Nasdaq Capital Market usaUSA
Immatics N.V. Immatics N.V.
IMTX
$ 6.73 2.0 % $ 823 M Nasdaq Global Select Market germanyGermany
Immunic Immunic
IMUX
$ 6.97 0.56 % $ 1.09 B Nasdaq Global Select Market usaUSA
Immunovant Immunovant
IMVT
$ 26.73 0.57 % $ 4.88 B Nasdaq Global Select Market usaUSA
MediciNova MediciNova
MNOV
$ 1.42 0.69 % $ 69.7 M Nasdaq Global Market usaUSA
Iovance Biotherapeutics Iovance Biotherapeutics
IOVA
$ 13.62 3.59 % $ 4.87 M Nasdaq Global Market,SPB usaUSA
Rezolute Rezolute
RZLT
$ 3.58 0.12 % $ 372 M Nasdaq Capital Market usaUSA
Aptose Biosciences Aptose Biosciences
APTO
- -45.71 % $ 1.2 M Nasdaq Capital Market canadaCanada

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.